Your browser doesn't support javascript.
loading
Immunotherapy choice and maintenance for generalized myasthenia gravis in China.
Zhang, Chao; Bu, Bitao; Yang, Huan; Wang, Lihua; Liu, Weibin; Duan, Rui-Sheng; Zhang, Meini; Zeng, Pei; Du, Chen; Yang, Li; Shi, Fu-Dong.
Afiliación
  • Zhang C; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China.
  • Bu B; National Clinical Research Center for Neurological Diseases of China, Jing-Jin Center for Neuroinflammation, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Yang H; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Wang L; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Liu W; Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.
  • Duan RS; Department of Neurology, The Second Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Zhang M; Department of Neurology, National Key Clinical Department and Key Discipline of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Zeng P; Department of Neurology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
  • Du C; Department of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, China.
  • Yang L; National Clinical Research Center for Neurological Diseases of China, Jing-Jin Center for Neuroinflammation, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Shi FD; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
CNS Neurosci Ther ; 26(12): 1241-1254, 2020 12.
Article en En | MEDLINE | ID: mdl-33103369

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Toma de Decisiones Clínicas / Factores Inmunológicos / Inmunosupresores / Inmunoterapia / Miastenia Gravis Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: CNS Neurosci Ther Asunto de la revista: NEUROLOGIA / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Toma de Decisiones Clínicas / Factores Inmunológicos / Inmunosupresores / Inmunoterapia / Miastenia Gravis Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: CNS Neurosci Ther Asunto de la revista: NEUROLOGIA / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: China
...